Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.

Nayak S, Norris JD, Ammirante M, Rychak E, Wardell SE, Liao D, Toyama B, Kandimalla R, Christoforou A, Tsuji T, Liu K, Tran M, Meiring J, Reiss S, Piccotti JR, Baughman JM, Fontanillo C, Khater M, Mortensen DS, Cathers B, Bence N, Pierce DW, Plantevin-Krenitsky V, Rathkopf D, Hansen JD, Hamann LG, Narla RK, Arora VK, McDonnell DP, Rolfe M, Xu S

Open source

DOI: 10.1158/1078-0432.ccr-25-0471
Published: 2026 Jan 6
Container: Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-25-0471,
  title = {Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.},
  author = {Nayak S and Norris JD and Ammirante M and Rychak E and Wardell SE and Liao D and Toyama B and Kandimalla R and Christoforou A and Tsuji T and Liu K and Tran M and Meiring J and Reiss S and Piccotti JR and Baughman JM and Fontanillo C and Khater M and Mortensen DS and Cathers B and Bence N and Pierce DW and Plantevin-Krenitsky V and Rathkopf D and Hansen JD and Hamann LG and Narla RK and Arora VK and McDonnell DP and Rolfe M and Xu S},
  year = {2026},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-25-0471},
  url = {https://doi.org/10.1158/1078-0432.ccr-25-0471}
}

RIS

TY  - JOUR
TI  - Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.
AU  - Nayak S
AU  - Norris JD
AU  - Ammirante M
AU  - Rychak E
AU  - Wardell SE
AU  - Liao D
AU  - Toyama B
AU  - Kandimalla R
AU  - Christoforou A
AU  - Tsuji T
AU  - Liu K
AU  - Tran M
AU  - Meiring J
AU  - Reiss S
AU  - Piccotti JR
AU  - Baughman JM
AU  - Fontanillo C
AU  - Khater M
AU  - Mortensen DS
AU  - Cathers B
AU  - Bence N
AU  - Pierce DW
AU  - Plantevin-Krenitsky V
AU  - Rathkopf D
AU  - Hansen JD
AU  - Hamann LG
AU  - Narla RK
AU  - Arora VK
AU  - McDonnell DP
AU  - Rolfe M
AU  - Xu S
PY  - 2026
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-25-0471
UR  - https://doi.org/10.1158/1078-0432.ccr-25-0471
ER  -

APA

S, N., JD, N., M, A., E, R., SE, W., D, L., B, T., R, K., A, C., T, T., K, L., M, T., J, M., S, R., JR, P., JM, B., C, F., M, K., DS, M., B, C., N, B., DW, P., V, P., D, R., JD, H., LG, H., RK, N., VK, A., DP, M., M, R., & S, X. (2026). Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-0471

Source records

pubmed · retrieved 2026-11-10T19:14:48.801Z